Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Erythropoietin treatment enhances muscle mitochondrial capacity in humans

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Clinically Valuable Quality Control for PET/MRI Systems: Consensus Recommendation From the HYBRID Consortium

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Propagation of Spermatogonial Stem Cell-Like Cells From Infant Boys

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Development and Feasibility of a Regulated, Supramaximal High-Intensity Training Program Adapted for Older Individuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Glucagon Receptor Signaling and Lipid Metabolism

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Acetaminophen toxicity induces mitochondrial complex I inhibition in human liver tissue

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Mitochondrial adaptations to high intensity interval training in older females and males

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Determination and validation of peak fat oxidation in endurance-trained men using an upper body graded exercise test

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Erythropoietin (Epo) treatment has been shown to induce mitochondrial biogenesis in cardiac muscle along with enhanced mitochondrial capacity in mice. We hypothesized that recombinant human Epo (rhEpo) treatment enhances skeletal muscle mitochondrial oxidative phosphorylation (OXPHOS) capacity in humans. In six healthy volunteers rhEpo was administered by sub-cutaneous injection over 8 weeks with oral iron (100 mg) supplementation taken daily. Mitochondrial OXPHOS was quantified by high-resolution respirometry in saponin-permeabilized muscle fibers obtained from biopsies of the vastus lateralis before and after rhEpo treatment. OXPHOS was determined with the mitochondrial complex I substrates malate, glutamate, pyruvate, and complex II substrate succinate in the presence of saturating ADP concentrations, while maximal electron transport capacity (ETS) was assessed by addition of an uncoupler. rhEpo treatment increased OXPHOS (from 92 ± 5 to 113 ± 7 pmol·s(-1)·mg(-1)) and ETS (107 ± 4 to 143 ± 14 pmol·s(-1)·mg(-1), p 
OriginalsprogEngelsk
Artikelnummer50
TidsskriftFrontiers in Physiology
Vol/bind3
ISSN1664-042X
DOI
StatusUdgivet - 2012

ID: 34799764